Novel biomarker beats leading diagnostic blood test at predicting Alzheimer's progression

Small loops of genetic material may be strong indicators of imminent Alzheimer's disease (AD) symptoms.

In a new study published in Nature Medicine, researchers showed that elevated levels of certain circular RNAs (circRNAs) in the blood nearly tripled patients' risk of developing symptoms, suggesting these molecules are more sensitive to symptom onset than traditional AD biomarkers. ...